We are live on ! Find out more
ACI

AMP Capital Investors Portfolio holdings

AUM $2.37B
1-Year Est. Return 23.59%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+23.59%
3 Year Est. Return
+89.65%
5 Year Est. Return
+139.34%
10 Year Est. Return
AUM
$18.6B
AUM Growth
+$854M
Cap. Flow
-$24.7M
Cap. Flow %
-0.13%
Top 10 Hldgs %
14.11%
Holding
1,258
New
125
Increased
402
Reduced
525
Closed
79

Top Sells

Rank Stock Value
1
EQR icon
Equity Residential
EQR
+$94.8M
2
SFR
Starwood Waypoint Homes
SFR
+$80.2M
3
PM icon
Philip Morris
PM
+$34.6M
4
MO icon
Altria Group
MO
+$29.2M
5
AAPL icon
Apple
AAPL
+$28.2M

Sector Composition

Rank Sector Weight
1 Real Estate 16.43%
2 Financials 13.89%
3 Technology 12.47%
4 Healthcare 9.13%
5 Consumer Discretionary 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTES icon
476
NetEase
NTES
$85.4B
$6.56M 0.04%
94,995
-199,550
-68% -$12.5M
ARW icon
477
Arrow Electronics
ARW
$10.3B
$6.55M 0.04%
81,460
+3,171
+4% +$255K
KSU
478
DELISTED
Kansas City Southern
KSU
$6.53M 0.04%
62,094
+24,107
+63% +$2.57M
ANDV
479
DELISTED
Andeavor
ANDV
$6.51M 0.04%
56,978
-3,731
-6% -$401K
EFX icon
480
Equifax
EFX
$21.3B
$6.51M 0.03%
55,177
-6,093
-10% -$685K
ANET icon
481
Arista Networks
ANET
$242B
$6.49M 0.03%
440,816
+83,200
+23% +$1.11M
GIB icon
482
CGI
GIB
$15.6B
$6.48M 0.03%
118,905
-30,972
-21% -$1.65M
JOYY
483
JOYY Inc
JOYY
$3.77B
$6.4M 0.03%
56,633
+5,333
+10% +$535K
TEVA icon
484
Teva Pharmaceuticals
TEVA
$42.1B
$6.39M 0.03%
337,382
-3,492
-1% -$52.5K
TRIP icon
485
TripAdvisor
TRIP
$1.26B
$6.38M 0.03%
185,108
+46,006
+33% +$1.66M
NTRS icon
486
Northern Trust
NTRS
$34.4B
$6.38M 0.03%
63,834
+3,026
+5% +$288K
FTS icon
487
Fortis
FTS
$28.3B
$6.37M 0.03%
173,072
-6,103
-3% -$225K
EQT icon
488
EQT Corp
EQT
$33.8B
$6.33M 0.03%
204,399
-4,262
-2% -$140K
WAT icon
489
Waters Corp
WAT
$40.4B
$6.28M 0.03%
32,494
+500
+2% +$96.5K
PAYX icon
490
Paychex
PAYX
$43.1B
$6.26M 0.03%
92,023
-33,295
-27% -$2.19M
VRSN icon
491
VeriSign
VRSN
$26.5B
$6.26M 0.03%
54,668
+10,100
+23% +$1.13M
AVY icon
492
Avery Dennison
AVY
$13.5B
$6.25M 0.03%
54,386
+26,376
+94% +$2.85M
CLX icon
493
Clorox
CLX
$13B
$6.22M 0.03%
41,843
+2,830
+7% +$385K
WRK
494
DELISTED
WestRock Company
WRK
$6.2M 0.03%
98,042
+1,066
+1% +$64.7K
BCE icon
495
BCE
BCE
$21B
$6.14M 0.03%
127,358
-47,752
-27% -$2.27M
AMH icon
496
American Homes 4 Rent
AMH
$12.3B
$6.12M 0.03%
280,128
+31,995
+13% +$694K
JNPR
497
DELISTED
Juniper Networks
JNPR
$6.07M 0.03%
213,056
-28,923
-12% -$781K
AGU
498
DELISTED
Agrium
AGU
$6.05M 0.03%
52,433
MRO
499
DELISTED
Marathon Oil Corporation
MRO
$6.03M 0.03%
355,940
+48,958
+16% +$727K
DVA icon
500
DaVita
DVA
$11.7B
$5.98M 0.03%
82,743
-30,556
-27% -$1.88M

Similar funds

AMP Capital Investors's Q4 2017 Portfolio in Review

As of Q4 2017, AMP Capital Investors held 1,258 positions worth $18.6B, up 4.8% from $17.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

AMP Capital Investors's Q4 2017 filing shows 125 new, 402 increased, 525 reduced and 79 closed positions. Its largest new stake was iShares Biotechnology ETF: 240,100 shares worth $25.6M. The largest sale was Equity Residential, an estimated $94.8M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

  • AMP Capital Investors's largest Q4 2017 buy was iShares Biotechnology ETF: 240,100 shares worth $25.6M.
  • AMP Capital Investors added most to iShares TIPS Bond ETF in Q4 2017, an estimated $193M increase.
  • AMP Capital Investors's biggest Q4 2017 reduction was Equity Residential, cutting an estimated $94.8M.
  • AMP Capital Investors fully exited Starwood Waypoint Homes in Q4 2017, selling an estimated $80.2M.
  • AMP Capital Investors's ten largest holdings make up 14% of its $18.6B portfolio in Q4 2017.
  • AMP Capital Investors opened 125 new positions and closed 79 in Q4 2017.
  • AMP Capital Investors's portfolio value rose 4.8% quarter-over-quarter to $18.6B.

Based on AMP Capital Investors's 13F filing for Q4 2017, filed 14 Feb 2018.